These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
352 related articles for article (PubMed ID: 9371735)
1. Induction of the E-selectin promoter by interleukin 1 and tumour necrosis factor alpha, and inhibition by glucocorticoids. Ray KP; Farrow S; Daly M; Talabot F; Searle N Biochem J; 1997 Dec; 328 ( Pt 2)(Pt 2):707-15. PubMed ID: 9371735 [TBL] [Abstract][Full Text] [Related]
2. Glucocorticoid inhibition of cytokine-induced E-selectin promoter activation. Ray KP; Searle N Biochem Soc Trans; 1997 May; 25(2):189S. PubMed ID: 9191233 [No Abstract] [Full Text] [Related]
3. CD38 expression is insensitive to steroid action in cells treated with tumor necrosis factor-alpha and interferon-gamma by a mechanism involving the up-regulation of the glucocorticoid receptor beta isoform. Tliba O; Cidlowski JA; Amrani Y Mol Pharmacol; 2006 Feb; 69(2):588-96. PubMed ID: 16291871 [TBL] [Abstract][Full Text] [Related]
4. Characterization of mechanisms involved in transrepression of NF-kappa B by activated glucocorticoid receptors. Scheinman RI; Gualberto A; Jewell CM; Cidlowski JA; Baldwin AS Mol Cell Biol; 1995 Feb; 15(2):943-53. PubMed ID: 7823959 [TBL] [Abstract][Full Text] [Related]
5. Hyperosmotic stimuli inhibit VCAM-1 expression in cultured endothelial cells via effects on interferon regulatory factor-1 expression and activity. Ochi H; Masuda J; Gimbrone MA Eur J Immunol; 2002 Jul; 32(7):1821-31. PubMed ID: 12115600 [TBL] [Abstract][Full Text] [Related]
6. Glucocorticoids inhibit the induction of nitric oxide synthase II by down-regulating cytokine-induced activity of transcription factor nuclear factor-kappa B. Kleinert H; Euchenhofer C; Ihrig-Biedert I; Förstermann U Mol Pharmacol; 1996 Jan; 49(1):15-21. PubMed ID: 8569701 [TBL] [Abstract][Full Text] [Related]
7. PPARalpha and GR differentially down-regulate the expression of nuclear factor-kappaB-responsive genes in vascular endothelial cells. Xu X; Otsuki M; Saito H; Sumitani S; Yamamoto H; Asanuma N; Kouhara H; Kasayama S Endocrinology; 2001 Aug; 142(8):3332-9. PubMed ID: 11459775 [TBL] [Abstract][Full Text] [Related]
8. Ligand-induced differentiation of glucocorticoid receptor (GR) trans-repression and transactivation: preferential targetting of NF-kappaB and lack of I-kappaB involvement. Adcock IM; Nasuhara Y; Stevens DA; Barnes PJ Br J Pharmacol; 1999 Jun; 127(4):1003-11. PubMed ID: 10433509 [TBL] [Abstract][Full Text] [Related]
9. E-selectin gene expression is induced synergistically with the coexistence of activated classic protein kinase C and signals elicited by interleukin-1beta but not tumor necrosis factor-alpha. Tamaru M; Narumi S J Biol Chem; 1999 Feb; 274(6):3753-63. PubMed ID: 9920928 [TBL] [Abstract][Full Text] [Related]
10. Interleukin-1alpha and tumour necrosis factor-alpha modulate airway smooth muscle DNA synthesis by induction of cyclo-oxygenase-2: inhibition by dexamethasone and fluticasone propionate. Vlahos R; Stewart AG Br J Pharmacol; 1999 Mar; 126(6):1315-24. PubMed ID: 10217524 [TBL] [Abstract][Full Text] [Related]
11. Dexamethasone prevents interleukin-1beta-induced nuclear factor-kappaB activation by upregulating IkappaB-alpha synthesis, in lymphoblastic cells. Castro-Caldas M; Mendes AF; Carvalho AP; Duarte CB; Lopes MC Mediators Inflamm; 2003 Feb; 12(1):37-46. PubMed ID: 12745547 [TBL] [Abstract][Full Text] [Related]
12. Dissociated glucocorticoids with anti-inflammatory potential repress interleukin-6 gene expression by a nuclear factor-kappaB-dependent mechanism. Vanden Berghe W; Francesconi E; De Bosscher K; Resche-Rigon M; Haegeman G Mol Pharmacol; 1999 Oct; 56(4):797-806. PubMed ID: 10496964 [TBL] [Abstract][Full Text] [Related]
13. Glucocorticoids inhibit E-selectin expression by targeting NF-kappaB and not ATF/c-Jun. Brostjan C; Anrather J; Csizmadia V; Natarajan G; Winkler H J Immunol; 1997 Apr; 158(8):3836-44. PubMed ID: 9103451 [TBL] [Abstract][Full Text] [Related]
14. Transcription of stem cell factor (SCF) is potentiated by glucocorticoids and interleukin-1beta through concerted regulation of a GRE-like and an NF-kappaB response element. Da Silva CA; Heilbock C; Kassel O; Frossard N FASEB J; 2003 Dec; 17(15):2334-6. PubMed ID: 14563684 [TBL] [Abstract][Full Text] [Related]
15. Effect of dexamethasone on interleukin-1beta-(IL-1beta)-induced nuclear factor-kappaB (NF-kappaB) and kappaB-dependent transcription in epithelial cells. Newton R; Hart LA; Stevens DA; Bergmann M; Donnelly LE; Adcock IM; Barnes PJ Eur J Biochem; 1998 May; 254(1):81-9. PubMed ID: 9652398 [TBL] [Abstract][Full Text] [Related]
16. Association of glucocorticoids and cyclosporin A or rapamycin prevents E-selectin and IL-8 expression during LPS- and TNFalpha-mediated endothelial cell activation. Charreau B; Coupel S; Goret F; Pourcel C; Soulillou JP Transplantation; 2000 Mar; 69(5):945-53. PubMed ID: 10755555 [TBL] [Abstract][Full Text] [Related]
17. Glucocorticoid-mediated suppression of cytokine-induced matrix metalloproteinase-9 expression in rat mesangial cells: involvement of nuclear factor-kappaB and Ets transcription factors. Eberhardt W; Schulze M; Engels C; Klasmeier E; Pfeilschifter J Mol Endocrinol; 2002 Aug; 16(8):1752-66. PubMed ID: 12145332 [TBL] [Abstract][Full Text] [Related]
18. Nuclear factor kappaB dominant negative genetic constructs inhibit X-ray induction of cell adhesion molecules in the vascular endothelium. Hallahan DE; Virudachalam S; Kuchibhotla J Cancer Res; 1998 Dec; 58(23):5484-8. PubMed ID: 9850083 [TBL] [Abstract][Full Text] [Related]
19. Distamycin prolongs E-selectin expression by interacting with a specific NF-kappaB-HMG-I(Y) binding site in the promoter. Ghersa P; Whelan J; Cambet Y; DeLamarter JF; Hooft van Huijsduijnen R Nucleic Acids Res; 1997 Jan; 25(2):339-46. PubMed ID: 9016563 [TBL] [Abstract][Full Text] [Related]
20. Negative cross-talk between RelA and the glucocorticoid receptor: a possible mechanism for the antiinflammatory action of glucocorticoids. Caldenhoven E; Liden J; Wissink S; Van de Stolpe A; Raaijmakers J; Koenderman L; Okret S; Gustafsson JA; Van der Saag PT Mol Endocrinol; 1995 Apr; 9(4):401-12. PubMed ID: 7659084 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]